Guideline for Selecting CPAP versus BiPAP in Acute Respiratory Failure

1. Indications and Decision Algorithm

2. Initial Ventilator Settings

CPAP

BiPAP

3. Contraindications

4. Monitoring, Failure Criteria, and Safety

5. Practical Considerations

Non-Invasive Ventilation Indications and Management

Primary Indications for NIV

• The British Thoracic Society recommends NIV for patients with acute exacerbation of COPD who have persistent respiratory acidosis with hypercapnia despite maximal medical treatment on controlled oxygen therapy 5, 6, 7
• The American Thoracic Society suggests that COPD exacerbation with respiratory acidosis is the strongest indication for NIV, with demonstrated reductions in intubation rates, hospital-acquired pneumonia, ICU length of stay, and mortality 5, 7
• The European Respiratory Society indicates that cardiogenic pulmonary edema that remains hypoxic despite maximal medical treatment should receive CPAP initially, and NIV should be reserved for patients in whom CPAP is unsuccessful or when hypercapnia develops 5, 6, 8
• The American College of Chest Physicians recommends NIV for acute or acute-on-chronic hypercapnic respiratory failure due to chest wall deformity or neuromuscular disease, including myasthenia gravis 5, 9
• The Society of Critical Care Medicine suggests that weaning from invasive ventilation when conventional weaning strategies fail, particularly in COPD patients, is a clear indication for NIV 5, 10

Conditional Indications and Contraindications

• The American Academy of Sleep Medicine recommends NIV for decompensated obstructive sleep apnea with respiratory acidosis, rather than CPAP alone 5, 6
• The Infectious Diseases Society of America indicates that immunocompromised patients with early acute respiratory failure may benefit from NIV over conventional oxygen therapy, with reduced intubation rates and mortality 10
• The European Society of Intensive Care Medicine suggests that absolute contraindications to NIV include recent facial/upper airway surgery, facial burns/trauma, fixed upper airway obstruction, vomiting, and recent upper GI surgery 5, 6
• The American Thoracic Society recommends that relative contraindications to NIV include severe bulbar dysfunction, copious secretions that cannot be cleared, and deteriorating consciousness requiring immediate intubation 5, 9, 7

Initial NIV Settings and Monitoring

• The British Thoracic Society recommends initial NIV settings of IPAP 8-12 cmH2O and EPAP 3-5 cmH2O, with lower pressures for neuromuscular patients 9, 7
• The American Thoracic Society suggests an initial FiO2 of 40%, titrated to SpO2 >92% (or 85-90% in COPD to avoid CO2 retention) 7
• The European Respiratory Society recommends using a full-face mask initially, transitioning to a nasal mask after 24 hours as the patient improves 5, 9, 7
• The American College of Chest Physicians suggests obtaining arterial blood gases at 1-2 hours to assess PaO2, PaCO2, and pH improvement, and expecting improvement by 4-6 hours 7